Clinical trials reveal a drug initially developed to treat some types of cancer now appears to help multiple sclerosis (MS) sufferers, a study said Thursday. The drug, alemtuzumab, proved effective in patient trials at reducing relapses -- a key feature of MS which sees symptoms appear sporadically. In one trial, patients who received the drug "were nearly half as likely to relapse within two years than those who received interferon", the most commonly-used ...Thursday, 1 November 2012
Cancer Drug Proves Effective in Treating Multiple Sclerosis Patients in Clinical Trials
Clinical trials reveal a drug initially developed to treat some types of cancer now appears to help multiple sclerosis (MS) sufferers, a study said Thursday. The drug, alemtuzumab, proved effective in patient trials at reducing relapses -- a key feature of MS which sees symptoms appear sporadically. In one trial, patients who received the drug "were nearly half as likely to relapse within two years than those who received interferon", the most commonly-used ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment